Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
Woman...without
her man ceases to feel, man ceases to love, and man ceases to live. I
wrote this for my sistas who may need a little reassurance that they
are beautiful as the Kreator made them and to not let society influence
their self worth. Yeah, I wrote this for my sistas, but its intention
is out of kommon respect for ALL women. Directed by Edward Osei-Gyimah
and Featuring T-Tru
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Black History Month is a time when all Americans honor the rich African American culture in our society. It was Carter G. Woodson, an African American historian, who began a weeklong celebration, called Negro History Week, in 1926 as a way to honor Frederick Douglass and Abraham Lincoln. One of the best ways to celebrate is by reading books by and about African Americans. Virginia Hamilton’s works are among the many books that call upon readers to think about slavery, freedom, and heritage. Through her stories, Hamilton began the genre of liberation literature, which serves to instill cultural pride, as well as a sense of family and the importance of relationships. Black History Month is a time to help readers realize that these universal themes transcend race and that through the power of story, all races are truly united. Non-fiction, Women's Lit, Liberation
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
OTC Markets Group Inc. (OTCQX: OTCM) and PR Newswire were joined by the UK’s Investor Relations Society in welcoming senior investor relations professionals to the latest instalment of their successful “No Blank Screens” series. The goal of the breakfast forum was to help educate European companies with global vision about the OTCQX® Best and OTCQB® Venture Marketplaces in the US, and to provide guidance and best practice tips on effectively engaging US investors. The event was held in the historic, Grade II listed One Moorgate Place in central London on 2nd July.
To view the Multimedia News Release, please go to http://www.multivu.com/players/English/7571051-trans-atlantic-information-flow/
For the past six years Brookdale, the nation’s largest senior living provider, has fulfilled its residents’ life-long dreams and Wishes by partnering with Wish of a Lifetime™, an organization dedicated to shifting the way society views and values our oldest generation. During this time, some of the most exciting Wishes have taken place in the skies above. Since the partnership began, more than 70 aerial themed Wishes have been granted to Brookdale residents who had dreams of skydiving, taking helicopter tours, flying fighter jets and more.
“Seeing our residents fulfill their Wish of a Lifetime through these incredible aviation adventures shows how older adults continue to act on their dreams and passions,” says Sara Terry, vice president of resident and family engagement. “We are always thrilled to find opportunities for our residents to enrich their lives and honor their spirit.”
To view the multimedia release go to:
http://www.multivu.com/players/English/77221510-brookdale-senior-wish-of-a-lifetime/
Klişe bir laf ama adamlar uzaya araç gönderirken, İslam dünyasında hâlâ dünya düz mü değil mi diye tartışılması gerçekten trajik. Bu tartışma birçok müslümana bile saçma gelecektir eminim. Ancak konu din olunca ve her şeyin ölçütü kutsal kitaplar olarak görüldüğünde, gerçeklerin orada yazanlara uydurulması bilindik bir durum haline gelmekte. İşte bu sebeple, 1975 yılında Suudi Arabistan'ın en önemli din otoritesi kabul edilen Şeyh Abdul Aziz Bin Baz tarafından Dünya'nın düz olduğu fetvası verilmiş ve buna inanmayanların dinsiz kabul edilerek, cezelandırılması gerektiği bildirilmiştir. Bugün, ülkemizde, hadisleri baz alarak Adem'in dinozorlarla aynı dönemde yaşadığını ve 30 m. uzunlukta olduğunu söyleyen biyoloji profesörlerimiz varken, dünyanın düz olduğunu söyleyen uzmanlar hiçbir müslümanı da şaşırtmamalı. ("Kuran'da Dünya'nın düz olarak geçtiğini söyleyenlere itirazınız var da, evrim yalandır diyenlere niye yok?" diye bir soru yönlendirilebilir kendilerine.)
Şüphesiz buna inananlar sadece müslümanlar değil. 1956 yılında Britanya'da, Flat Earth Society (Düz Dünya Cemiyeti) adıyla, Dünya'nın düz olduğunu savunan ve bugün hala aktif olan bir organizasyon bile kuruldu. Bilim karşıtlığı hiçbir zaman popülaritesini yitirmiyor.
Konuyla ilgili olarak aşağıdaki kaynaklara bakmanızı da tavsiye ederim:
http://www.bilimfelsefedin.org/?p=377
http://suphecimelek.wordpress.com/2010/05/21/gunesin-battigi-yer/
http://www.mucizeyalanlari.com/gunesin-gidis-istikameti/
http://wikiislam.net/wiki/Flat_Earth_and_the_Qur%27an (İngilizce)
http://www.loc.gov/exhibits/world/images/s104.jpg (Zekeriya bin Mahmut el Kazvini'nin 16. yy'da Arapça'dan Türkçe'ye çevrilmiş astronomi kitabı Acaibul Mahlukat'tan alınan bu tasvirde, Dünya bir büyükbaş hayvanın üzerinde duran düz bir disk olarak tasvir ediliyor.)
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
The Kokuryukai Black Dragon Society, IFAA International Fighting Arts Association has recognized Laoshi Douwe Geluk in 2019. Douwe Geluk is a martial arts master from Apeldoorn city in the Netherlands and founder of Tai Chi Apeldoorn Bron van Geluk Fu Yuan
The Heart Rhythm Society (HRS), through its efforts during Atrial Fibrillation Awareness Month in September and throughout the year, is working to raise awareness of the increased prevalence of the disease and the associated risk of stroke in patients living with atrial fibrillation (AFib). Today, HRS releases a new public service announcement (PSA) as part of its ongoing work to educate Americans about AFib, the most common heart arrhythmia, and how it increases one’s risk of stroke fivefold. The PSA can be viewed by clicking here.
AFib affects more than three million Americans and it is estimated that 12 to 16 million Americans will have AFib by 2050. AFib occurs when the upper chambers of the heart (the atria) fibrillate, or “quiver,” which causes a rapid, irregular heart rhythm. The normal heart rate for an adult is between 60 and 100 beats every minute. When the heart is experiencing AFib, the atria can beat over 300 times every minute.
To view the multimedia release go to:
http://www.multivu.com/players/English/7312151-heart-rhythm-society-afib-stroke-psa/
